OBJECTIVE	This prospective , randomized , double-blind multicenter trial evaluated the efficacy and safety of a single bolus injection of the novel modified tissue-type plasminogen activator ( t-PA ) E6010 in the treatment of acute myocardial infarction compared with that of native t-PA .\